New Key Statistics Module, Z-Score and F-Score
NAS:CPRX Key Ratios
| Market Cap $ M | 1,882.75 |
| Enterprise Value $ M | 1,575.81 |
| P/E(ttm) | 29.52 |
| PE Ratio without NRI | 29.52 |
| Forward PE Ratio | 10.19 |
| Price/Book | 3.35 |
| Price/Sales | 4.42 |
| Price/Free Cash Flow | 23.58 |
| Price/Owner Earnings | 76.63 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 411.00 |
| EPS (TTM) $ | 0.54 |
| Beneish M-Score | -2.75 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -15.50 |
| EV-to-EBIT | 20.12 |
| EV-to-EBITDA | 13.82 |
| PEG | -- |
| Shares Outstanding M | 118.12 |
| Net Margin (%) | 15.83 |
| Operating Margin % | 19.04 |
| Pre-tax Margin (%) | 20.98 |
| Quick Ratio | 4.83 |
| Current Ratio | 5.09 |
| ROA % (ttm) | 13.67 |
| ROE % (ttm) | 16.22 |
| ROIC % (ttm) | 24.67 |
| Dividend Yield % | -- |
| Altman Z-Score | 15.24 |
CPRX Number of Guru Trades
CPRX Volume of Guru Trades
Gurus Latest Trades with NAS:CPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CPRX is held by these investors
Total 2
Catalyst Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:CPRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers